HOME >> BIOLOGY >> NEWS
Other highlights in the September 1 JNCI

Study Investigates How Neuroblastoma Treatment Promotes Apoptosis

Retinoic acid therapy has been used as a treatment for neuroblastoma, but the drug can also make some neuroblastoma cells resistant to chemotherapy. Because fenretinide, a derivative of retinoic acid, targets a different molecular pathway--one that induces apoptosis, or programmed cell death--in neuroblastoma cells and is well tolerated, there has been interest in using fenretinide to treat neuroblastoma. In a study of fenretinide's activity within neuroblastoma cells, Chris P. F. Redfern, Ph.D., of the University of Newcastle upon Tyne in England, and colleagues characterize a novel pathway that mediates the fenretinide induction of apoptosis, and suggest that this pathway may be a target for future drug development. In addition, because fenretinide increased the level of a neuroblastoma cell marker--one that is targeted by immunotherapy--it may be able to work in conjunction with immunotherapy agents, the authors write.

Contact: University of Newcastle upon Tyne Press Office, 44-191-222-7850, press.office@ncl.ac.uk

Novel Compound Shows Activity Against Glucose-Deprived Tumors

Versipelostatin, a novel compound isolated from a microorganism, disrupts a stress-related pathway in glucose-deprived cancer cells and inhibits tumor growth in mice, according to a new study.

Tumors can become glucose- and oxygen-deprived when they lack blood vessels, which transport these molecules. Cells deprived of glucose accumulate unfolded proteins, but such cells survive this stress by turning on a special molecular pathway--the unfolded protein response--that protects cells from the harmful effects of unfolded proteins. Researchers have hypothesized that glucose-deprived tumor cells could be killed by disrupting this pathway.

Kazuo Shin-ya, Ph.D., of the University of Tokyo, and collea
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
31-Aug-2004


Page: 1 2 3

Related biology news :

1. Other highlights in the August 18 JNCI
2. Other highlights in the August 4 JNCI
3. Other highlights in the July 7 JNCI
4. Other highlights in the June 16 JNCI
5. Other Highlights in the June 2 JNCI
6. Other highlights in the May 19 JNCI
7. Other highlights in the May 5 JNCI
8. Other highlights of the March 17 issue of JNCI
9. Other highlights in the March 3 issue of JNCI
10. Other highlights in the February 18 issue of JNCI
11. Other highlights in the February 4 issue of JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/1/2018)... ... August 01, 2018 , ... RURO, Inc., a ... version 7.1. Limfinity® is the software framework that all of RURO’s products are ... both current users and the future of RURO’s laboratory software portfolio. , To ...
(Date:8/1/2018)... ... 2018 , ... Visikol CEO Dr. Michael Johnson has announced that through the ... Visikol will far exceed its original 2018 revenue projections. , Over the last ... pathology tools, whole mount imaging techniques and advanced 3D cell ...
(Date:7/31/2018)... ... July 31, 2018 , ... ... Muzek as Business Development Manager. In this role, Mr. Muzek will lead the ... Lifecycle’s continued growth and expansion. , With over 20 years in business ...
Breaking Biology News(10 mins):
(Date:8/9/2018)... ... August 08, 2018 , ... ActX ... and is continually updated by a talented scientific team that includes geneticists, PharmD’s, ... , 1. Information on the medical impact of a patient’s genetic variants ...
(Date:8/9/2018)... ... August 09, 2018 , ... ... Rockland, and Dr. Birte Aggeler, Director of Antibody Development at Bio-Techne, composed a ... article was published online on August 9, 2018 and will be printed in ...
(Date:8/1/2018)... (PRWEB) , ... August 01, ... ... healer, today announces research results on the significant impact of a proprietary ... responses. , The preclinical research assessed biomarkers for systemic and organ-specific ...
(Date:7/27/2018)... ... July 27, 2018 , ... ... Advocacy Group (BRAG®) and representatives of the Biotechnology Innovation Organization (BIO) met ... recently-issued white paper, “Proposal for a Toxic Substances Control Act (TSCA) Inventory ...
Breaking Biology Technology:
Cached News: